Yıl: 2018 Cilt: 60 Sayı: 1 Sayfa Aralığı: 14 - 18 Metin Dili: İngilizce DOI: 10.26657/gulhane.00010 İndeks Tarihi: 09-05-2019

Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?

Öz:
Aims: We aimed to evaluate whether there is a specific subgroupof patients who benefit most from PSAD screening accordingto their prostate volume.Methods: Transrectal ultrasound guided prostate biopsy performedpatients were stratified in five groups according to theirprostate size. PSAD values were compared between groups,and the diagnostic accuracy of PSAD was evaluated for differentprostate volumes.Results: Of 326 patients 98 (30.0%) had pCa. While total PSA andPSAD between pCa(+) and (-) patients were significantly higherin group 1,2 and 3, the differences was not significant in group4 and 5. The highest AUC value was achieved for group 3 andthe lowest for group 5. The optimal cutoff values were differentbetween groups.Conclusions: Demonstrating the greatest diagnostic accuracyof PSAD in prostates ≥60 and <80 cc makes an invaluable contributionto the current literature and would be a reference pointfor further studies.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Tosoian J, Loeb S. PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer. Scientific World Journal. 2010;10:1919-1931.
  • Chen CS, Wang SS, Li JR, et al. PSA density as a better predictor of prostate cancer than percent-free PSA in a repeat biopsy. J Chin Med Assoc. 2011;74(12):552-555.
  • Bazinet M, Meshref AW, Trudel C, et al. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology. 1994;43(1):44-51; discussion 51-52.
  • Seaman E, Whang M, Olsson CA, Katz A, Cooner WH, Benson MC. PSA density (PSAD). Role in patient evaluation and management. Urol Clin North Am. 1993;20(4):653-663.
  • Di Donna A, Bazzocchi M, Guerra UP, et al. The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma: a comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy. Radiol Med 1993;85:84e9.
  • Lin DW, Gold MH, Ransom S, Ellis WJ, Brawer MK. Transition zone prostate specific antigen density: lack of use in prediction of prostatic carcinoma. J Urol. 1998;160(1):77-81.
  • Adhyam M, Gupta AK. A Review on the Clinical Utility of PSA in Cancer Prostate. Indian J Surg Oncol. 2012;3(2):120-129.
  • Benson MC, Whang IS, Pantuck A, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol. 1992;147(3 Pt 2):815-816.
  • Andriole GL, Telle WB, Coplen DE, Catalona WJ. PSA index (PSAI) as a predictor of prostate cancer in men with persis- tent serum PSA elevation (abstract). J Urol 1992;147:387A
  • Rommel FM, Agusta VE, Breslin JA, et al. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol. 1994;151:88–93.
  • Catalona WJ, Richie JP, deKernion JB, et al. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol 1994;152:2031.
  • Ciatto S, Bonardi R, Lombardi C, et al. Predicting prostate biopsy outcome by findings at digital rectal examination, transrectal ultrasonography, PSA, PSA density and free-to-total PSA ratio in a population-based screening setting. Int J Biol Markers. 2001;16:179–182.
  • Ohori M, Dunn JK, Scardino PT. Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer? Urology. 1995; 46:666–671.
  • Stephan C, Stroebel G, Heinau M, et al. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL. Cancer. 2005;104(5):993-1003.
APA zor m, kaya e, Bedir S (2018). Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?. , 14 - 18. 10.26657/gulhane.00010
Chicago zor murat,kaya engin,Bedir Selahattin Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?. (2018): 14 - 18. 10.26657/gulhane.00010
MLA zor murat,kaya engin,Bedir Selahattin Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?. , 2018, ss.14 - 18. 10.26657/gulhane.00010
AMA zor m,kaya e,Bedir S Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?. . 2018; 14 - 18. 10.26657/gulhane.00010
Vancouver zor m,kaya e,Bedir S Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?. . 2018; 14 - 18. 10.26657/gulhane.00010
IEEE zor m,kaya e,Bedir S "Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?." , ss.14 - 18, 2018. 10.26657/gulhane.00010
ISNAD zor, murat vd. "Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?". (2018), 14-18. https://doi.org/10.26657/gulhane.00010
APA zor m, kaya e, Bedir S (2018). Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?. Gülhane Tıp Dergisi, 60(1), 14 - 18. 10.26657/gulhane.00010
Chicago zor murat,kaya engin,Bedir Selahattin Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?. Gülhane Tıp Dergisi 60, no.1 (2018): 14 - 18. 10.26657/gulhane.00010
MLA zor murat,kaya engin,Bedir Selahattin Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?. Gülhane Tıp Dergisi, vol.60, no.1, 2018, ss.14 - 18. 10.26657/gulhane.00010
AMA zor m,kaya e,Bedir S Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?. Gülhane Tıp Dergisi. 2018; 60(1): 14 - 18. 10.26657/gulhane.00010
Vancouver zor m,kaya e,Bedir S Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?. Gülhane Tıp Dergisi. 2018; 60(1): 14 - 18. 10.26657/gulhane.00010
IEEE zor m,kaya e,Bedir S "Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?." Gülhane Tıp Dergisi, 60, ss.14 - 18, 2018. 10.26657/gulhane.00010
ISNAD zor, murat vd. "Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?". Gülhane Tıp Dergisi 60/1 (2018), 14-18. https://doi.org/10.26657/gulhane.00010